Fairvoy Private Wealth LLC Invests $1.68 Million in iShares Biotechnology ETF $IBB

Fairvoy Private Wealth LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the first quarter, Holdings Channel reports. The institutional investor bought 9,965 shares of the financial services provider’s stock, valued at approximately $1,683,000.

Other large investors have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC grew its holdings in shares of iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after buying an additional 46,806 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $1,907,000. Tudor Investment Corp ET AL purchased a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $931,000. WorthPointe LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $1,424,000. Finally, Central Pacific Bank Trust Division lifted its position in iShares Biotechnology ETF by 296,500.0% during the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after acquiring an additional 14,825 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $183.67 on Friday. The stock’s 50 day simple moving average is $171.22 and its 200-day simple moving average is $170.92. iShares Biotechnology ETF has a 12-month low of $125.70 and a 12-month high of $186.81.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were given a $0.0238 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Monday, June 15th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.